Tympanogenic labyrinthitis.
D002781:Cholesteatoma / Q000150:complications / Q000473:pathology; D003051:Cochlea / Q000503:physiopathology; D006259:Craniocerebral Trauma / Q000150:complications; D004427:Ear Diseases / Q000150:complications / Q000473:pathology; D004432:Ear, Middle / Q000601:surgery; D005276:Fenestration, Labyrinth / Q000009:adverse effects; D005402:Fistula / Q000209:etiology / Q000473:pathology; D006311:Hearing Disorders / Q000209:etiology; D006801:Humans; D007249:Inflammation; D007759:Labyrinth Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D010033:Otitis Media / Q000150:complications / Q000473:pathology; D011183:Postoperative Complications; D012887:Skull Fractures / Q000150:complications; D013201:Stapes Surgery / Q000009:adverse effects; D014722:Vestibule, Labyrinth / Q000503:physiopathology